Sensex rebounds by 214 points

April 22, 2015 05:12 pm | Updated 05:12 pm IST - Mumbai

The benchmark BSE Sensex on Wednesday rebounded by over 214 points to 27,890.13 on value-buying in capital goods, pharma and banking stocks as sentiment improved after Saudi Arabia ended its military campaign in Yemen.

The 30-share BSE barometer gained over 151 points on value-based buying in bluechip stocks. But on reports of subdued monsoon forecast, the gauge slipped into the negative zone to touch the day’s low of 27,385.48.

A flurry of buying in the last one hour boosted the index to the day’s high of 27,947.26, before settling with a gain of 214.19 points or 0.77 per cent at 27,890.13.

On similar lines, the 50-share NSE Nifty, recaptured the crucial 8,400 mark by gaining 51.95 points or 0.62 per cent, to close at 8,429.70.

Shares of Hindustan Unilever topped the Sensex gainers by surging 3.59 per cent.

Shares of Sun Pharma also made a comeback on Wednesday to close 1.63 per cent higher at Rs 967.15, a day after Japan’s Daiichi Sankyo sold its entire in the company for Rs 20,025 crore.

Other gainers on the Sensex included, L&T 3.29 per cent, Axis Bank 3.19 per cent, Dr Reddy’s 3.04 per cent, M&M 2.03 per cent, Tata Power 1.61 per cent and HDFC 1.60 per cent.

However, Shares of Wipro plunged over 6 per cent to Rs 544 after company’s earnings failed to enthuse investors.

Sectorally, the BSE capital goods gained the most by rising 1.88 per cent, followed by healthcare 1.20 per cent, banking index 0.78 per cent and FMCG 0.52 per cent.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.